RYTM

RYTM Operating Cash Flow (Statement)

-$149.53MTTM · USD

Period ending:

RYTM FY Cash from OperationsUSD
RYTM FY Cash from Operations2012-12-31: -$17.83M2013-12-31: -$19.16M2014-12-31: -$7.51M2015-12-31: -$6.98M2016-12-31: -$23.22M2017-12-31: -$29.46M2018-12-31: -$62.06M2019-12-31: -$122.75M2020-12-31: -$121.98M2021-12-31: -$146.00M2022-12-31: -$173.43M2023-12-31: -$136.16M2024-12-31: -$113.88M2025-12-31: -$115.68M$0.00-$173.43M
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RYTM operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Rhythm Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-115,675,000
-113,879,000
-136,157,000
-173,428,000
-146,003,000
-121,980,000
-122,750,000
-62,056,000
-29,460,000
-23,219,000
-6,977,000
-7,508,000
-19,156,000
-17,830,000

Compare operating cash flow (statement)

All RYTM financial metrics · RYTM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.